Quercetin 3-O-β-d-galactopyranoside has the ability to protect human melanocytes from oxidative damage, possibly through activation of AKT, inhibition of p38 phosphorylation, and suppression of mitochondrial apoptotic signaling, which offering a novel avenue for the treatment vitiligo (48). This evidence concerns the gene AKT1 and vitiligo.